Posted on 11 February, 2012
What the EU is trying to do with this trade agreement is effectively slowly poison the production of affordable generic medicines in India, which has helped keep so many people alive. This trade agreement could target us as treatment providers, simply for buying generic medicines from India to treat patients in our programs.
Piero Gandini
Head of Mission for MSF in India
India has been called the “pharmacy of the developing world” because it produces a large number of high-quality, affordable generic medicines. MSF and other treatment providers also rely on Indian generic medicines to treat other diseases and conditions.
However, a free trade agreement (FTA) currently under negotiation between the European Union (EU) and India could greatly restrict the ability of Indian generic manufacturers to continue producing high-quality, affordable medicines that millions of people with HIV/AIDS and other diseases and conditions rely on to stay alive.
To learn more about the protests and the issue at hand read this briefing on the situation.
For more information also check out MSF’s Access Campaign website.
What the EU is trying to do with this trade agreement is effectively slowly poison the production of affordable generic medicines in India, which has helped keep so many people alive. This trade agreement could target us as treatment providers, simply for buying generic medicines from India to treat patients in our programs.
Piero Gandini
Head of Mission for MSF in India
India has been called the “pharmacy of the developing world” because it produces a large number of high-quality, affordable generic medicines. MSF and other treatment providers also rely on Indian generic medicines to treat other diseases and conditions.
However, a free trade agreement (FTA) currently under negotiation between the European Union (EU) and India could greatly restrict the ability of Indian generic manufacturers to continue producing high-quality, affordable medicines that millions of people with HIV/AIDS and other diseases and conditions rely on to stay alive.
To learn more about the protests and the issue at hand read this briefing on the situation.
For more information also check out MSF’s Access Campaign website.
MSF took to the streets with 2,000 others in New Delhi warning that harmful provisions in a trade deal between the EU and India could severely hinder access to affordable medicine for people in developing countries.
For more information about the protest go here.
For more photographs from the demonstration go here.
Photo:India 2012 © Syddharth Singh
WARNING: These testimonies contain graphic descriptions of violence.
MSF is not authorized to operate inside Syria at present and thus is unable to fully verify the information collected here. However, given the recurring nature, consistency, and severity of the acts described in these testimonies, MSF has decided to make them public. For security reasons, names and locations have been withheld.
“When I fell on the ground, two men who unfortunately were from the Syrian army came to me and started to beat me on my head and my injured leg.”
–Man, 28 years old, laborer
Date of injury: May 2011
Click here to view more testimonials of the victims in Syria.